Multiple Sclerosis
Conference Coverage
Ibudilast shows promise in progressive MS
SAN DIEGO – Imaging results proved favorable, and clinical endpoints will be forthcoming.
Conference Coverage
MS may be a transmissible protein misfolding disorder, study suggests
SAN DIEGO – Researchers transmit condition to transgenic mice via injections of human brain matter.
Conference Coverage
VIDEO: Could targeting gut dysbiosis in MS prevent disease?
SAN DIEGO – Transgenic mouse studies lead to questions of altering gut flora to prevent disease in people at high risk for multiple sclerosis.
Conference Coverage
Rituximab fails to eliminate meningeal inflammation in progressive MS
But study findings still offer new insights to researchers seeking to dampen the immune system in the brain’s lining.
Conference Coverage
Fingolimod cuts pediatric MS relapse rate more than interferon beta-1a
The PARADIGMS study is the first international controlled trial to test fingolimod in pediatric patients.
Conference Coverage
Study finds rising use of newer DMTs in pediatric-onset MS
Newer disease-modifying therapies often used in pediatric-onset MS patients appear to have short-term side effect profiles similar to those in...
Conference Coverage
Barancik Prize winner to discuss MS biology advances
University of Cambridge’s Dr. Robin Franklin will highlight recent findings about the crucial process of remyelination at ACTRIMS Forum 2018.
Conference Coverage
Researcher’s talk will tackle aging and gut bacteria in MS
In the Kenneth P. Johnson Memorial Lecture, Dr. Suhayl Dhib-Jalbut will talk about links between gut dysbiosis and aging in the onset of MS.
Conference Coverage
ACTRIMS Forum 2018 highlights MS therapeutic targets
Scientific program committee chair Dr. Benjamin M. Segal discusses what to look for at the San Diego meeting.
Literature Review
Generic Glatiramer Acetate Remains Safe and Effective for Two Years
Generic glatiramer acetate remains effective and safe over two years of treatment for patients with relapsing-remitting multiple sclerosis (MS),...
From the Journals
2017 update to McDonald criteria loosens MS diagnosis somewhat
Changes to the 2010 McDonald multiple sclerosis diagnostic criteria aim to promote earlier diagnosis and discourage misdiagnosis.